Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension of M15-741 evaluating continuous subcutaneous ABBV-951 in Parkinson's disease
jRCT2080225358Phase 3Recruiting
- Sponsor
- AbbVie Inc.
- Start
- Aug 2020
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of foscarbidopa in Parkinson's disease (PD), sponsored by AbbVie Inc. Started Aug 2020; status: recruiting.
02
Drugs
foscarbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080225358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225358.